Related Experiment Video
Updated: Jun 19, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force
1U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland, USA.
Insights
The U.S. Preventive Services Task Force found insufficient evidence to recommend novel risk factors for screening coronary heart disease (CHD) in asymptomatic individuals. More research is needed to determine benefits and harms for preventing CHD events.
Area of Science:
- Cardiology
- Preventive Medicine
- Risk Assessment
Background:
- The U.S. Preventive Services Task Force (USPSTF) evaluated novel risk factors for coronary heart disease (CHD) in asymptomatic individuals.
- Traditional risk assessment for CHD often relies on factors like the Framingham score.
Purpose of the Study:
- To assess the utility of nine nontraditional CHD risk factors in refining risk stratification for asymptomatic individuals.
- To determine if these novel markers can effectively reclassify intermediate-risk individuals to high- or low-risk strata for targeted interventions.
Main Methods:
- Conducted systematic literature reviews of studies published since 1996 on nine proposed nontraditional CHD risk markers.
- Included high-sensitivity C-reactive protein, ankle-brachial index, leukocyte count, fasting blood glucose, periodontal disease, carotid intima-media thickness, coronary artery calcification, homocysteine, and lipoprotein(a).
- Employed a hierarchical approach to evaluate the practical and definitive reassignment capabilities of these markers.
Main Results:
- Evidence was reviewed for nine nontraditional markers: hs-CRP, ABI, WBC, glucose, periodontal disease, CIMT, CAC, homocysteine, Lp(a).
- The goal was to see if these markers could effectively reclassify individuals from intermediate to high or low CHD risk.
- The hierarchical approach aimed to identify markers with practical and definitive reassignment capabilities.
Conclusions:
- The USPSTF concluded that current evidence is insufficient to assess the benefits and harms of using these novel risk factors for screening.
- This applies to asymptomatic men and women with no prior history of CHD.
- Further research is required to establish the role of these markers in preventing CHD events.
Description:
New recommendation from the U.S. Preventive Services Task Force (USPSTF) on the use of nontraditional, or novel, risk factors in assessing the coronary heart disease (CHD) risk of asymptomatic persons.
Methods:
Systematic reviews were conducted of literature since 1996 on 9 proposed nontraditional markers of CHD risk: high-sensitivity C-reactive protein, ankle-brachial index, leukocyte count, fasting blood glucose, periodontal disease, carotid intima-media thickness, coronary artery calcification score on electron-beam computed tomography, homocysteine, and lipoprotein(a). The reviews followed a hierarchical approach aimed at determining which factors could practically and definitively reassign persons assessed as intermediate-risk according to their Framingham score to either a high-risk or low-risk strata, and thereby improve outcomes by means of aggressive risk-factor modification in those newly assigned to the high-risk stratum.
Recommendation:
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of using the nontraditional risk factors studied to screen asymptomatic men and women with no history of CHD to prevent CHD events. (I statement).
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis III: Management
Relative Risk
Coronary Artery Disease V: Interprofessional Care